Physiotherapy for Improving Mental Health in Children and Adolescents With ASD and ADHD
The Role of Physiotherapy in the Mental Health of Children and Adolescents With Neurodevelopmental Disorders: A Randomized Controlled Trial
1 other identifier
interventional
117
1 country
1
Brief Summary
This study investigates whether a structured physiotherapy program can help reduce symptoms of stress, anxiety, and depression in children and adolescents diagnosed with Autism Spectrum Disorder (ASD) or Attention-Deficit/Hyperactivity Disorder (ADHD). ASD and ADHD are neurodevelopmental conditions often associated with emotional and behavioral challenges, including elevated levels of psychological distress. The physiotherapy intervention includes techniques such as diaphragmatic breathing, acupressure, relaxation exercises, proprioceptive activities, and therapeutic positions designed to support emotional regulation. Children aged 6-18 years are randomly assigned to either an intervention group receiving the physiotherapy program or a control group receiving usual care. The purpose of the study is to evaluate whether this physiotherapy protocol can positively influence emotional well-being and behavioral indicators related to ASD and ADHD. Outcomes are assessed using validated questionnaires measuring stress, anxiety, depression, and disorder-related behavioral characteristics before and after the intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 28, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 15, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
July 15, 2023
CompletedFirst Submitted
Initial submission to the registry
November 13, 2025
CompletedFirst Posted
Study publicly available on registry
November 17, 2025
CompletedNovember 17, 2025
November 1, 2025
1 year
November 13, 2025
November 13, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Change in Stress Levels (DASS-21 Stress Subscale)
Stress levels assessed using the DASS-21 Stress Subscale (score range 0-42). Higher scores indicate higher stress. The outcome will be analyzed as the change in score from baseline to post-intervention.
Baseline and post-intervention (after 10 sessions - approximately 5 weeks)
Change in Anxiety Levels (DASS-21 Anxiety Subscale)
Stress/anxiety levels assessed using the DASS-21 Anxiety Subscale (score range 0-42). Higher scores indicate greater anxiety symptoms. The outcome will be analyzed as the change in score from baseline to post-intervention.
Baseline and post-intervention (after 10 sessions - approximately 5 weeks)
Change in Depression Levels (DASS-21 Depression Subscale)
Depression levels assessed using the DASS-21 Depression Subscale (score range 0-42). Higher scores indicate higher depressive symptoms. The outcome will be analyzed as the change in score from baseline to post-intervention.
Baseline and post-intervention (after 10 sessions - approximately 5 weeks)
Secondary Outcomes (2)
Change in Autism-Related Behavioral Indicators (CAST Score)
Baseline and post-intervention (after 10 sessions - approximately 5 weeks)
Change in ADHD-Related Behavioral Indicators (ADHD Parent Questionnaire Score)
Baseline and post-intervention (after 10 sessions - approximately 5 weeks)
Study Arms (2)
Physiotherapy Intervention Group
EXPERIMENTALParticipants receive a structured physiotherapy program designed to improve emotional regulation, reduce anxiety symptoms, and enhance overall mental health. The program includes sensorimotor exercises, coordination training, postural activities, and structured physical activity tailored to children and adolescents with ASD or ADHD.
Comparator Group
NO INTERVENTIONParticipants do not receive physiotherapy during the study period but continue their usual daily routines. After study completion, they are offered the physiotherapy program.
Interventions
A structured multimodal physiotherapy program including sensorimotor integration exercises, balance and coordination training, postural control activities, therapeutic physical activity, breathing regulation techniques, and proprioceptive stimulation. The intervention is tailored to children and adolescents with ASD or ADHD and aims to improve emotional regulation, reduce anxiety, enhance behavioral self-control, and promote overall mental health.
Eligibility Criteria
You may qualify if:
- Diagnosis of Autism Spectrum Disorder (ASD) or Attention Deficit Hyperactivity Disorder (ADHD) by a qualified clinician.
- Age between 6 and 18 years.
- Ability to participate in structured physiotherapy sessions.
- Stable medication regimen (if applicable) for at least 4 weeks prior to study entry.
- Parent/guardian consent and child assent (where applicable).
- Ability of parents/guardians to comply with study procedures and assessments.
You may not qualify if:
- Severe intellectual disability that prevents participation in physiotherapy activities.
- Uncontrolled epilepsy or other neurological disorders that pose safety risks.
- Severe sensory or motor impairments preventing safe exercise participation.
- Participation in another clinical study within the last 3 months.
- Any acute medical condition deemed unsafe for physical activity.
- Behavioral issues that prevent structured participation (e.g., aggressive behavior).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hippokratio General Hospital of Thessaloniki - Child Psychiatry Department
Thessaloniki, 546 42, Greece
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Illias Kallistratos
International Hellenic University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- The outcomes assessor was blinded to group assignment to minimize assessment bias.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
November 13, 2025
First Posted
November 17, 2025
Study Start
June 28, 2022
Primary Completion
July 15, 2023
Study Completion
July 15, 2023
Last Updated
November 17, 2025
Record last verified: 2025-11
Data Sharing
- IPD Sharing
- Will not share
Participant-level data will not be shared in order to protect confidentiality, as the dataset includes sensitive information from children and adolescents